245 related articles for article (PubMed ID: 15906026)
1. T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil.
Mellstedt H; Choudhury A
Cancer Immunol Immunother; 2006 Feb; 55(2):210-20. PubMed ID: 15906026
[TBL] [Abstract][Full Text] [Related]
2. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia.
Rezvany MR; Jeddi-Tehrani M; Rabbani H; Lewin N; Avila-Cariño J; Osterborg A; Wigzell H; Mellstedt H
Br J Haematol; 2000 Nov; 111(2):608-17. PubMed ID: 11122109
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL.
Kokhaei P; Rezvany MR; Virving L; Choudhury A; Rabbani H; Osterborg A; Mellstedt H
Leukemia; 2003 May; 17(5):894-9. PubMed ID: 12750703
[TBL] [Abstract][Full Text] [Related]
4. In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2003 Jan; 131(1):82-9. PubMed ID: 12519390
[TBL] [Abstract][Full Text] [Related]
5. Autologous T lymphocytes recognize the tumour-derived immunoglobulin VH-CDR3 region in patients with B-cell chronic lymphocytic leukaemia.
Rezvany MR; Jeddi-Tehrani M; Rabbani H; Rudén U; Hammarström L; Osterborg A; Wigzell H; Mellstedt H
Br J Haematol; 2000 Oct; 111(1):230-8. PubMed ID: 11091206
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
[TBL] [Abstract][Full Text] [Related]
7. Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivity.
Weigand LU; Liang X; Schmied S; Mall S; Klar R; Stötzer OJ; Salat C; Götze K; Mautner J; Peschel C; Krackhardt AM
Immunology; 2012 Nov; 137(3):226-38. PubMed ID: 23025755
[TBL] [Abstract][Full Text] [Related]
8. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
9. Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2001 Oct; 126(1):16-28. PubMed ID: 11678895
[TBL] [Abstract][Full Text] [Related]
10. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
Scrivener S; Goddard RV; Kaminski ER; Prentice AG
Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
[TBL] [Abstract][Full Text] [Related]
11. Prolegomenon for chronic lymphocytic leukaemia.
Vitale B; Martinis M; Antica M; Kusić B; Rabatić S; Gagro A; Kusec R; Jaksić B
Scand J Immunol; 2003 Dec; 58(6):588-600. PubMed ID: 14636414
[TBL] [Abstract][Full Text] [Related]
12. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
[TBL] [Abstract][Full Text] [Related]
13. Tumour-loaded α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile.
Gustafsson K; Junevik K; Werlenius O; Holmgren S; Karlsson-Parra A; Andersson PO
Scand J Immunol; 2011 Sep; 74(3):318-326. PubMed ID: 21595737
[TBL] [Abstract][Full Text] [Related]
14. B-cell maturation in chronic lymphocytic leukaemia. IV. T-cell-dependent activation of leukaemic B cells by staphylococcal enterotoxin 'superantigens'.
Duan X; Nerl C; Janssen O; Kabelitz D
Immunology; 1992 Mar; 75(3):420-6. PubMed ID: 1572690
[TBL] [Abstract][Full Text] [Related]
15. Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemia.
Vuillier F; Maloum K; Thomas EK; Magnac C; Dumas G; Payelle-Brogard B; Oppezzo P; Dighiero G; Scott-Algara D
Br J Haematol; 2003 Jan; 120(2):243-50. PubMed ID: 12542481
[TBL] [Abstract][Full Text] [Related]
16. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
Fernandez LA; MacSween JM; Langley GR
Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
[TBL] [Abstract][Full Text] [Related]
17. Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells.
Müller MR; Tsakou G; Grünebach F; Schmidt SM; Brossart P
Blood; 2004 Mar; 103(5):1763-9. PubMed ID: 14615377
[TBL] [Abstract][Full Text] [Related]
18. Impaired mitogen responses of the non-leukaemic B cells from patients with chronic lymphocytic leukaemia.
Morgan A; Eaves J; Mockford JW; Malkovska V
Clin Exp Immunol; 1989 Aug; 77(2):239-44. PubMed ID: 2789117
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern.
Rezvany MR; Jeddi-Tehrani M; Biberfeld P; Söderlund J; Mellstedt H; Osterborg A; Rabbani H
Br J Haematol; 2001 Nov; 115(2):263-71. PubMed ID: 11703320
[TBL] [Abstract][Full Text] [Related]
20. Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia.
Tonino SH; van de Berg PJ; Yong SL; ten Berge IJ; Kersten MJ; van Lier RA; van Oers MH; Kater AP
Leuk Lymphoma; 2012 Sep; 53(9):1785-94. PubMed ID: 22397719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
